ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.11 May, 11 2023 12:17 PM Anebulo Pharmaceuticals Inc. 2023-05-11 12:17:22 ET Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q1 GAAP EPS of -$0.11. Cash was $14.2 million as of March 31, 2023. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.11